{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:07:00Z","timestamp":1794956820528,"version":"4.9.1"},"reference-count":51,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:p>Adult-onset dystonia can be acquired, inherited or idiopathic. The dystonia is usually focal or segmental and for a limited number of cases causal treatment is available. In recent years, rapid developments in neuroimmunology have led to increased knowledge on autoantibody-related dystonias. At the same time, genetic diagnostics in sequencing technology have evolved and revealed several new genes associated with adult-onset dystonia. Furthermore, new phenotype\u2013genotype correlations have been elucidated. Consequently, clinicians face the dilemma of which additional investigations should be performed and whether to perform genetic testing or not. To ensure early diagnosis and to prevent unnecessary investigations, integration of new diagnostic strategies is needed.<\/jats:p><jats:p>We designed a new five-step diagnostic approach for adult-onset dystonia. The first four steps are based on a broad literature search and expert opinion, the fifth step, on when to perform genetic testing, is based on a detailed systematic literature review up to 1 December 2021.<\/jats:p><jats:p>The basic principle of the algorithm is that genetic testing is unlikely to lead to changes in management in three groups: (1) patients with an acquired form of adult-onset dystonia; (2) patients with neurodegenerative disorders, presenting with a combined movement disorder including dystonic symptoms and (3) patients with adult-onset isolated focal or segmental dystonia. Throughout the approach, focus lies on early identification of treatable forms of dystonia, either acquired or genetic.<\/jats:p><jats:p>This novel diagnostic approach for adult-onset dystonia can help clinicians to decide when to perform additional tests, including genetic testing and facilitates early aetiological diagnosis, to enable timely treatment.<\/jats:p>","DOI":"10.1136\/jnnp-2021-328120","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T17:39:32Z","timestamp":1654882772000},"page":"1039-1048","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["A novel diagnostic approach for patients with adult-onset dystonia"],"prefix":"10.1136","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2648-6937","authenticated-orcid":false,"given":"Martje E","family":"van Egmond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4967-866X","authenticated-orcid":false,"given":"Tjerk J","family":"Lagrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gintaute","family":"Lizaitiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marenka","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5783-571X","authenticated-orcid":false,"given":"Marina A J","family":"Tijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,6,10]]},"reference":[{"key":"2022093006451065000_93.10.1039.1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25475"},{"key":"2022093006451065000_93.10.1039.2","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/mds.28560","article-title":"Is Adult\u2010Onset dystonia a rare disease? time for Population\u2010Based studies","volume":"36","author":"Defazio","year":"2021","journal-title":"Mov Disord"},{"key":"2022093006451065000_93.10.1039.3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/WCO.0000000000000956","article-title":"Autoimmune movement disorders with neuronal antibodies - an update","volume":"34","author":"Balint","year":"2021","journal-title":"Curr Opin Neurol"},{"key":"2022093006451065000_93.10.1039.4","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25244"},{"key":"2022093006451065000_93.10.1039.5","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13133"},{"key":"2022093006451065000_93.10.1039.6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/mdc3.13376","article-title":"Current guidelines for classifying and diagnosing cervical dystonia: empirical evidence and recommendations","volume":"9","author":"Kilic-Berkmen","year":"2022","journal-title":"Mov Disord Clin Pract"},{"key":"2022093006451065000_93.10.1039.7","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28485"},{"key":"2022093006451065000_93.10.1039.8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41572-018-0023-6","article-title":"Dystonia","volume":"4","author":"Balint","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2022093006451065000_93.10.1039.9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mds.27140","article-title":"Treatable inherited rare movement disorders","volume":"33","author":"Jinnah","year":"2018","journal-title":"Mov Disord."},{"key":"2022093006451065000_93.10.1039.10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/mds.26937","article-title":"A post hoc study on gene panel analysis for the diagnosis of dystonia","volume":"32","author":"van Egmond","year":"2017","journal-title":"Mov Disord."},{"key":"2022093006451065000_93.10.1039.11","first-page":"50","article-title":"Increased diagnostic yield in complex dystonia through exome sequencing","volume":"2020","author":"Wirth","year":"2019","journal-title":"Park Relat Disord"},{"key":"2022093006451065000_93.10.1039.12","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/mds.28597","article-title":"\u201cAntibody of Unknown Significance\u201d (AUS): The Issue of Interpreting Antibody Test Results","volume":"36","author":"Balint","year":"2021","journal-title":"Mov Disord"},{"key":"2022093006451065000_93.10.1039.13","doi-asserted-by":"crossref","unstructured":"Moher D , Liberati A , Tetzlaff J , et al . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.doi:10.1371\/journal.pmed.1000097","DOI":"10.1371\/journal.pmed.1000097"},{"key":"2022093006451065000_93.10.1039.14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/mds.26527","article-title":"Nomenclature of genetic movement disorders: recommendations of the International Parkinson and movement disorder Society Task force","volume":"31","author":"Marras","year":"2016","journal-title":"Mov Disord."},{"key":"2022093006451065000_93.10.1039.15","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22597"},{"key":"2022093006451065000_93.10.1039.16","doi-asserted-by":"crossref","unstructured":"Evatt ML , Freeman A , Factor S . Adult-Onset dystonia. Vol 100. 1st ed. Elsevier B.V., 2011.","DOI":"10.1016\/B978-0-444-52014-2.00037-9"},{"key":"2022093006451065000_93.10.1039.17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/mdc3.12459","article-title":"Fatigue, sleep disturbances, and their influence on quality of life in cervical dystonia patients","volume":"4","author":"Smit","year":"2017","journal-title":"Mov Disord Clin Pract"},{"key":"2022093006451065000_93.10.1039.18","doi-asserted-by":"crossref","unstructured":"Friedman J , ed. Medication-Induced Movement Disorders. Cambridge: Cambridge University Press, 2015.","DOI":"10.1017\/CBO9781107588738"},{"key":"2022093006451065000_93.10.1039.19","first-page":"203","article-title":"Drug-Induced movement disorders","volume":"42","author":"Mehta","year":"2012","journal-title":"Mov Disord Neurol Syst Dis"},{"key":"2022093006451065000_93.10.1039.20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.psc.2016.04.003","article-title":"Drug-Induced extrapyramidal syndromes: implications for contemporary practice","volume":"39","author":"Caroff","year":"2016","journal-title":"Psychiatr Clin North Am"},{"key":"2022093006451065000_93.10.1039.21","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2015.00130"},{"key":"2022093006451065000_93.10.1039.22","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1016\/S1353-8020(13)70028-2","article-title":"Tardive dyskinesia syndromes: current concepts","volume":"20 Suppl 1","author":"Aquino","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"2022093006451065000_93.10.1039.23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/ene.13762","article-title":"Dystonia: diagnosis and management","volume":"26","author":"Albanese","year":"2019","journal-title":"Eur J Neurol"},{"key":"2022093006451065000_93.10.1039.24","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-017-0709-2","article-title":"Autoimmune movement disorders: a clinical and laboratory approach","volume":"17","author":"Honorat","year":"2017","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2022093006451065000_93.10.1039.25","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2016.12.1.1"},{"key":"2022093006451065000_93.10.1039.26","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx189"},{"key":"2022093006451065000_93.10.1039.27","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/mds.27446","article-title":"The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disorders","volume":"33","author":"Damato","year":"2018","journal-title":"Mov Disord"},{"key":"2022093006451065000_93.10.1039.28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2013.02.007","article-title":"Movement disorders in multiple sclerosis and other demyelinating diseases","volume":"328","author":"Mehanna","year":"2013","journal-title":"J Neurol Sci"},{"key":"2022093006451065000_93.10.1039.29","doi-asserted-by":"publisher","DOI":"10.1177\/1352458508094883"},{"key":"2022093006451065000_93.10.1039.30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s42466-020-0053-x","article-title":"Antibody-related movement disorders \u2013 a comprehensive review of phenotype-autoantibody correlations and a guide to testing","volume":"2","author":"G\u00f6vert","year":"2020","journal-title":"Neurol. Res. Pract."},{"key":"2022093006451065000_93.10.1039.31","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4103\/0972-2327.138503","article-title":"Movement disorders of probable infectious origin","volume":"17","author":"Jhunjhunwala","year":"2014","journal-title":"Ann Indian Acad Neurol"},{"key":"2022093006451065000_93.10.1039.32","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870060206"},{"key":"2022093006451065000_93.10.1039.33","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/mds.20883","article-title":"Movement disorders associated with hyperthyroidism: expanding the phenotype","volume":"21","author":"Tan","year":"2006","journal-title":"Mov. Disord."},{"key":"2022093006451065000_93.10.1039.34","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25549"},{"key":"2022093006451065000_93.10.1039.35","first-page":"976","article-title":"The dystonias","volume":"25","author":"Jinnah","year":"2019","journal-title":"Continuum"},{"key":"2022093006451065000_93.10.1039.36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.parkreldis.2019.07.030","article-title":"Dystonia in atypical parkinsonian disorders","volume":"66","author":"Marsili","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"2022093006451065000_93.10.1039.37","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000324625.00404.15"},{"key":"2022093006451065000_93.10.1039.38","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26987"},{"key":"2022093006451065000_93.10.1039.39","first-page":"513","article-title":"[Criteria for the diagnosis of corticobasal degeneration]","volume":"67","author":"Shimohata","year":"2015","journal-title":"Brain Nerve"},{"key":"2022093006451065000_93.10.1039.40","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004058"},{"key":"2022093006451065000_93.10.1039.41","doi-asserted-by":"publisher","DOI":"10.3171\/2015.9.FOCUS15497"},{"key":"2022093006451065000_93.10.1039.42","doi-asserted-by":"crossref","first-page":"vii7","DOI":"10.1007\/s00415-006-7003-6","article-title":"Dystonia in Parkinson\u2019s disease","volume":"253","author":"Tolosa","year":"2006","journal-title":"J Neurol"},{"key":"2022093006451065000_93.10.1039.43","doi-asserted-by":"crossref","unstructured":"Postuma RB , Berg D . The New Diagnostic Criteria for Parkinson\u2019s Disease. 132. 1st ed. Elsevier Inc, 2017.","DOI":"10.1016\/bs.irn.2017.01.008"},{"key":"2022093006451065000_93.10.1039.44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5692\/clinicalneurol.50.147","article-title":"[Case of dementia with Lewy bodies showing cervical dystonia after donepezil administration]","volume":"50","author":"Hasegawa","year":"2010","journal-title":"Rinsho Shinkeigaku"},{"key":"2022093006451065000_93.10.1039.45","doi-asserted-by":"crossref","first-page":"418","DOI":"10.5692\/clinicalneurol.cn-000843","article-title":"Dementia with Lewy bodies presenting marked tongue protrusion and bite due to lingual dystonia: a case report","volume":"56","author":"Shiga","year":"2016","journal-title":"Rinsho Shinkeigaku"},{"key":"2022093006451065000_93.10.1039.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2005.10.004"},{"key":"2022093006451065000_93.10.1039.47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/ene.13762","article-title":"Dystonia: diagnosis and management","volume":"26","author":"Albanese","year":"2019","journal-title":"Eur J Neurol"},{"key":"2022093006451065000_93.10.1039.48","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S1474-4422(19)30033-X","article-title":"Clinical application of next-generation sequencing to the practice of Neurology","volume":"18","author":"Rexach","year":"2019","journal-title":"The Lancet Neurology"},{"key":"2022093006451065000_93.10.1039.49","unstructured":"Zech M , Jech R , Boesch S . Scoring algorithm-based genomic testing in dystonia: a prospective validation study. Mov Disord. Published online 2021:1\u20137."},{"key":"2022093006451065000_93.10.1039.50","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30312-4"},{"key":"2022093006451065000_93.10.1039.51","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-309106"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2021-328120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T13:49:57Z","timestamp":1664545797000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2021-328120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,10]]},"references-count":51,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,9,14]]},"published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.1136\/jnnp-2021-328120"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2021-328120","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,10]]}}}